Rationale of a comparative analytical study on matrix metalloproteinases associated with genital prolapse in Congolese women from the town of Kananga in the Democratic Republic of Congo: research protocol

Antoine Tshimbundu Kayembe; Andy Mbangama Muela; Rahma Raschid Tozin

doi:10.18203/2320-1770.ijrcog20233851

Authors

Antoine Tshimbundu Kayembe Department of Gynaecology and Obstetrics, Faculty of Medicine, University Notre-Dame of Kasayi, Central Kasaï, D.R. Congo https://orcid.org/0000-0003-2685-340X
Andy Mbangama Muela Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Kinshasa, Kinshasa, D.R. Congo https://orcid.org/0000-0003-2972-7708
Rahma Raschid Tozin Department of Gynaecology and Obstetrics, Faculty of Medicine, University of Kinshasa, Kinshasa, D.R. Congo https://orcid.org/0000-0003-4767-9519

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20233851

Keywords:

Epidemiology, Matrix metalloproteinases, Genital prolapse, Kananga, DR Congo

Abstract

Background: Genital prolapse is a pelvic static disorder associated with urinary, digestive and genital disorders which bother the patient. The fear of these discomforts has pushed many Western countries to adopt beneficial preventive measures for women at risk, notably the administration of estrogen-progestogens and the prevention of obstetric trauma. These two preventive factors play an inhibitory role on matrix metalloproteinases degrading the collagens which ensure ligament firmness. This link between matrix metalloproteinases and collagen is implicated by many researchers in the occurrence of genital prolapse. Objectives are to determine the epidemiological and clinical profile of genital prolapse, to identify the non-molecular factors associated with it, to determine the level of matrix metalloproteinases-1, -2 and -9 in non-prolapsed and prolapsed pelvic tissues, and to identify the types MMPs associated with genital prolapse in Congolese women from the town of Kananga in central Kasai in DR Congo.

Methods: We designed a protocol for a comparative analytical study focusing on the epidemiology and the level of matrix metalloproteinases in non-prolapsed and prolapsed pelvic tissues in the Bon-Berger and Saint Georges hospitals in the city of Kananga. Women over 40 years of age and of any parity suffering from genital prolapse and other benign gynecological pathologies requiring hysterectomy will be included in the study according to non-probabilistic convenience sampling.

Conclusions: This study will evaluate the level of matrix metalloproteinases-1, -2 and -9 in prolapsed tissues and identify the type of matrix metalloproteinases most associated with genital prolapse in our setting.

Metrics

Metrics Loading ...

References

Lansac J, Lecomte P, Marret H. Gynécologie pour le praticien. 8ème Edition Elsevier Masson, Paris. 2012;131-48.

Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM. Prevalence and co-occurrence of pelvic floor disorders in community welling women. Obstet Gynecol. 2008;111(3):678-85.

Shah AD, Kohli N, Rajan SS, Hoyte L. The age distribution, rates, and types of surgery for stress urinary incontinence in the USA. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(1):89-96.

Karl M, Luber KM, Boero S, Choe JY. The demographics of pelvic floor disorders: current observations and future projections. Am J Obstet Gynecol. 2001;184:1496-503.

Subak LL, Waetjen LE, Van den eaden S, Thom DH, Vittinghoff E, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001;98:646-51.

Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979—1997. Am J Obstet Gynecol. 2003;188:108-15.

Bradley CS, Zimmerman MB, Wang Q, Nygaard IE. Vaginal descent and pelvic floor symptoms in postmenopausal women: a longitudinal study. Obstet Gynecol. 2008;111(5):1148-53.

Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol. 2001;185(6):1388-95.

Barber MD, Neubauer NL, Klein-olarte V. Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies? Am J Obstet Gynecol. 2006;195(4):942-8.

Miedel A, Tegerstedt G, Maehle-schmidt M, Nyren O, Hammarström M. Symptoms and pelvic support defects in specific compartments. Obstet Gynecol. 2008;112(4):851-8.

Handa VL, Garrett E, Hendrix S, Gold E, Robbins J. Progression andr remission of pelvic organ prolapse: A longitudinal study of menopausal women. Am J Obstet Gynecol. 2004;190:27-32.

Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, Mctiernan A. Pelvic organ prolapse in the Women’s Health initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160-6.

Nygaard I, Bradley C, Brandt D. Pelvic organ prolapse in older women: prevalence ond risk factors. Obstet Gynecol. 2004;104(3):489-97.

Ntabe NE, Bosse R, Mumbere M. Profil des Patientes opérées à l’Hôpital Général de HEAL AFRICA et à l’Hôpital Général de Référence de BÉNI, Province du Nord Kivu, République Démocratique du Congo. Available athttps://hal-auf.archives-ouvertes.fr/hal-01325953. Accessed on 09 October 2023.

Tshimbundu KA, Mbangama MA, Mutombo BA, Sengeyi MA, Tozin R. Genital prolapse : epidemiology, clinic and therapeutic at Saint Joseph Hosital of Kinshasa. Panafr Med J. 2020;37(196):14-23.

Kieserman-Shmokler C, Swenson WC, Chen L, Desmond L, Ashton-Miller JA, DeLancey JO. From molecular to macro : the key role of the apical ligaments in uterovaginal support. Am J Obstet Gynecol. 2020;427-36.

Wong M, Ozgur H, Agar M, Dandolu V, Grody T. Collagen content of nonsupport tissue in pelvic organ prolapse and stress urinary incontinence. Am J Obstet Gynecol. 2003;189(6):1597-9.

Dviri M, Leron E, Dreiher J, Mazor M, Shaco-Levy R. Increased matrix metalloproteinases-1, -9 in the uterosacral ligaments and vaginal tissue from women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2011;156:113-7.

Chow D, Rodriguez LV. Epidemiology and prevalence of pelvic organ prolapse. Curr Opin Urol. 2013;23:293-8.

Chiaffarino F, Chatenoud L, Dindelli M. Reproductive factors, family history, occupation and risk of urogenital prolapse. Eur J Obstet Gynecol Reprod Biol. 2009;82(1):63-7.

Aytan H, Ertunç D, Ekrem CT, Yasa O, Nazik H. Prevalence of pelvic organ prolapse and related factors in a general female population. J Turk Soc Obstet Gynecol. 2014;3:176-80.

Tshimbundu KA, Kitenge KC, Kamba JP, Tozin R. Factors associated with genital prolapse at Saint-Joseph Hospital of Kinshasa. Panafri Med J. 2021;40(234):1-9.

Strinic T, Vulic M, Tomic S, Capkun V, Stipic I, Alujevic I. Matrix metalloproteinases- 1, -2 expression in uterosacral ligaments from women with pelvic organ prolapse. Maturitas. 2009;64:132-5.

Towers GD. The pathophysiology of pelvic organ prolapse. J Pelvic Med Surg. 2004;10:109-22.

Weber AM, Richter HE. Pelvic organ prolapse. Obstet Gynecol. 2005;106:615-34.

Strinic T, Bukovic D, Roje D, Milic N, Pavic M, Seso I. Epidemiology of pelvic floor disorders between urban and rural female inhabitants. Coll Antropol. 2007;31:315-9.

Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J. 2002;13:80-7.

Boris G, Denschlag D, Göbel H. Uterosacral ligament in postmenopausal women with or without pelvic organ prolapse. Int Urogynecol J. 2005;16:475-9.

Boris G, Watermann D, Hancke K, Gitsch G, Werner M, Tempfer C, et al. Increased expression of matrix metalloproteinase 2 in uterosacral ligaments is associated with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2006;17:478-82.

Alperin M, Moalli PA. Remodeling of vaginal connective tissue in patients with prolapse. Curr Opin Obstet Gynecol. 2006;18:544-50.

Phillips CH, Anthony F, Benyon C, Monga AK. Collagen metabolism in the uterosacral ligaments and vaginal skin of women with uterine prolapse. Br J Obstet Gynaecol. 2006;113:39-46.

Moalli PA, Shand SH, Zyczynski HM, Gordy SC, Meyn LA. Remodeling of vaginal connective tissue in patients with prolapse. Obstet Gynecol. 2005;106:953-63.

Usta A, Guzin K, Kanter M, Ozgül M, Usta CS. Expression of matrix metalloproteinase-1 in round ligament and uterosacral ligament tissue from women with pelvic organ prolapse. J Mol Histol. 2014;45:275-81.

Vulic M, Strinic T, Tomic S, Capkun V, Alujevic-Jakus I, Ivica S. Difference in expression of collagen type I and matrix metalloproteinase-1 in uterosacral ligaments of women with and without pelvic organ prolapse Euro J Obstet Gynecol Reprod Biol. 2011;156:83-7.

Liang CC, Huang HY, Tseng LH, Chang SD, Lo TS, Lee CL. Expression of matrix metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 (TIMP-1, TIMP-2 and TIMP-3) in women with uterine prolapse but without urinary incontinence. Euro J Obstet Gynecol Reprod Biol. 2010;153:94-8.

Patterson ML, Atkinson SJ, Kna¨uper V, Murphy G. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain. FEBS Lett. 2001;503:158-62.

Laronha H, Caldeira J. Structure and Function of Human Matrix Metalloproteinases. Cells. 2020;9(1076):1-18.

Marchenko ND, Marchenko GN, Weinreb RN, Lindsey JD, Kyshtoobayeva A, Crawford HC, et al. Beta-catenin regulates the gene of MMP-26, a novel metalloproteinase expressed both in carcinomas and normal epithelial cells. Int J Biochem Cell Biol. 2004;36:942-56.

Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing heart. Circ Res. 2002;90:520-30.

Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metallo-proteinases: structure, function, and biochemistry. Circ Res. 2003;92:827-39.

Han YP, Tuan TL, Hughes M, Wu H, Garner WL. Transforming growth factor-beta– and tumor necrosis factor-alpha–mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem. 2001;276:22341-50.

Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ. Changes in metabolism of collagen in genito-urinary prolapse. Lancet. 1996;347:1658-61.

Kerkhof MH, Hendriks L, Bro¨lmann HA. Changes in connective tissue in patients with pelvic organ prolapse—a review of the current literature. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20:461-74.

Visco AG, Yuan L. Differential gene expression in pubococcygeus muscle from patients with pelvic organ prolapse. Am J Obstet Gynecol. 2003;189:102-12.

Lousquy R, Costa P, Delmas V, Haab F. Etat de lieux de l’épidémiologie des prolapsus génitaux. Progrès en Urol. 2009;19:907-15.

Dällenbach P, Kaelin-gambirasio I, Dubuisson JB, Boulvain M. Risk factors for pelvic organ prolapse repair after hysterectomy. Obstet Gynecol. 2007;110(3):625-32.